Liwei Ma

机构：First Affiliated Hospital of Zhengzhou University · ORCID：0009-0006-0132-616X

发表论文 8 篇 · 总被引 144 次 · h-index 7

代表论文

• TMEM44-AS1 promotes esophageal squamous cell carcinoma progression by regulating the IGF2BP2-GPX4 axis in modulating ferroptosis (2023 · Cell Death Discovery · 被引 30)
• TRIM25 promotes temozolomide resistance in glioma by regulating oxidative stress and ferroptotic cell death via the ubiquitination of keap1 (2023 · Oncogene · 被引 30)
• Obesity accelerates immune evasion of non-small cell lung carcinoma via TFEB-dependent upregulation of Siglec-15 and glycolytic reprogramming (2022 · Cancer Letters · 被引 18)
• Ferroptosis-associated circular RNAs: Opportunities and challenges in the diagnosis and treatment of cancer (2023 · Frontiers in Cell and Developmental Biology · 被引 16)
• Long non‐coding RNA HOXC‐AS1 exerts its oncogenic effects in esophageal squamous cell carcinoma by interaction with IGF2BP2 to stabilize SIRT1 expression (2022 · Journal of Clinical Laboratory Analysis · 被引 16)
• Combination therapy: Photochemotherapy; electric current; and ionizing radiation. Different combinations studied in a WiDr human colon adenocarcinoma cell line (1993 · Journal of Photochemistry and Photobiology B Biology · 被引 16)